Defining Optimal Immunotherapies for Type 1 Diabetes

Introduction: whither gene–environment interactions?

2. Rudolf Uher

Gene–environment interaction: overcoming methodological challenges

Discussion

3. Marco Battaglia, Cecilia Marino, Michel Maziade, Massimo Molteni and Francesca D’Amato

Gene–environment interaction and behavioural disorders: a developmental perspective based on endophenotypes

Discussion

4. Naomi R. Wray, William L. Coventry, Michael R. James, Grant W. Montgomery, Lindon J. Eaves and Nicholas G. Martin

Use of monozygotic twins to investigate the relationship between 5HTTLPR genotype, depression and stressful life events: an application of Item Response Theory

Discussion

Appendix

General discussion I

5. Harold Snieder, Xiaoling Wang, Vasiliki Lagou, Brenda W. J. H. Penninx, Harriëtte Riese and Catharina A. Hartman

Role of gene–stress interactions in gene-finding studies

Discussion

6. Kenneth A. Dodge

Practice and public policy in the era of gene–environment interactions

Discussion

7. Kristi B. Adamo and Frédérique Tesson

Gene–environment interaction and the metabolic syndrome

Discussion

General discussion II

8. Stephen P. Robertson and Richie Poulton

Longitudinal studies of gene–environment interaction in common diseases—good value for money?

Discussion

9. Kee-Seng Chia

Gene–environment interactions in breast cancer

Discussion

10. Malak Kotb, Nourtan Abdeltawab, Ramy Aziz, Sarah Rowe, Robert W. Williams and Lu Lu

Unbiased forward genetics and systems biology approaches to understanding how gene–environment interactions work to predict susceptibility and outcomes of infections

Discussion

11. Steven R. Kleeberger and Hye-Youn Cho

Gene–environment interactions in environmental lung diseases

Discussion

General discussion III

12. Fernando D. Martinez

Gene–environment interaction in complex diseases: asthma as an illustrative case

Discussion

13. Michael Rutter

Conclusions: taking stock and looking ahead

Glossary

Index of contributors

Subject index